Simultaneous generation of multiple mitochondrial DNA mutations in human prostate tumors suggests mitochondrial hyper-mutagenesis

Carcinogenesis

Volumn 24, Issue 9, 2003, Pages 1481-1487

  Chen, Junjian Z ^a   Gokden, Neriman ^b   Greene, Graham F ^c   Green, Bridgett ^a   Kadlubar, Fred F ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

ARTICLE; CELL ACTIVITY; CELL KINETICS; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE FREQUENCY; GENE MUTATION; HUMAN; HUMAN TISSUE; LASER; MUTAGENESIS; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE TUMOR; SENSITIVITY AND SPECIFICITY; TUMOR CELL LINE; TUMOR GROWTH;

BASE SEQUENCE; DNA, MITOCHONDRIAL; HUMANS; MALE; MODELS, GENETIC; MUTATION; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS;

EID: 0141703199     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgg102     Document Type: Article

References (34)

1. Loeb, L.A. (1991) Mutator phenotype may be required for multistage carcinogenesis. Cancer Res., 51, 3075-3079.
2. Loeb, L.A. (2001) A mutator phenotype in cancer. Cancer Res., 61, 3230-3239.
3. Wallace, D.C. (1999) Mitochondrial diseases in man and mouse. Science, 283, 1482-1488.
4. Penta, J.S., Johnson, F.M., Wachsman, J.T. and Copeland, W.C. (2001) Mitochondrial DNA in human malignancy. Mutat. Res., 488, 119-133.
5. Polyak, K., Li, Y., Zhu, H., Lengauer, C., Willson, J.K., Markowitz, S.D., Trush, M.A., Kinzler, K.W. and Vogelstein, B. (1998) Somatic mutations of the mitochondrial genome in human colorectal tumours. Nature Genet., 20, 291-293.
6. Fliss, M.S., Usadel, H., Caballero, O.L., Wu, L., Buta, M.R., Eleff, S.M., Jen, J. and Sidransky, D. (2000) Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science, 287, 2017-2019.
7. Jones, J.J., Song, J.J., Hempen, P.M., Parmigiani, G., Hruban, R.H. and Kern, S.E. (2001) Detection of mitochondrial DNA mutations in pancreatic cancer offer a 'mass'-ive advantage over detection of nuclear DNA mutations. Cancer Res., 61, 1299-1304.
8. Kirches, E., Krause, G., Warich-Kirches, M., Weis, S., Schneider, T., Meyer-Puttlitz, B., Mawrin, C. and Dietzmann, K. (2001) High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples. Int. J. Cancer, 93, 534-538.
9. Liu, V.W., Shi, H.H., Cheung, A.N., Chiu, P.M., Leung, T.W., Nagley, P., Wong, L.C. and Ngan, H.Y. (2001) High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res., 61, 5998-6001.
10. Jeronimo, C., Nomoto, S., Caballero, O.L., Usadel, H., Henrique, R., Varzim, G., Oliveira, J., Lopes, C., Fliss, M.S. and Sidransky, D. (2001) Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene, 20, 5195-5198.
11. Parrella, P., Xiao, Y., Fliss, M. et al. (2001) Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res., 61, 7623-7626.
12. Nishikawa, M., Nishiguchi, S., Shiomi, S. et al. (2001) Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma. Cancer Res., 61, 1843-1845.
13. Shay, J.W. and Werbin, H. (1987) Are mitochondrial DNA mutations involved in the carcinogenic process? Mutat. Res., 186, 149-160.
14. Coller, H.A., Khrapko, K., Bodyak, N.D., Nekhaeva, E., Herrero-Jimenez, P. and Thilly, W.G. (2001) High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nature Genet., 28, 147-150.
15. Carter, H.B., Piantadosi, S. and Isaacs, J.T. (1990) Clinical evidence for and implications of the multistep development of prostate cancer. J. Urol., 143, 742-746.
16. Oesterling, J., Fuks, Z., Lee, C.T. and Scher, H.I. (1997) Cancer of the Prostate. In DeVita, V.T., Hellman, S. and Rosenberg, S.A. (eds), Cancer: Principles and Practice of Oncology, 5th Edn. Lippincott-Raven, Philadelphia, pp. 1322-1385.
17. Costello, L.C. and Franklin, R.B. (2000) The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy. Oncology, 59, 269-282.
18. Lee, W.H., Morton, R.A., Epstein, J.I., Brooks, J.D., Campbell, P.A., Bova, G.S., Hsieh, W.S., Isaacs, W.B. and Nelson, W.G. (1994) Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl Acad. Sci. USA, 91, 11733-11737.
19. Lee, W.H., Isaacs, W.B., Bova, G.S. and Nelson, W.G. (1997) CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker. Cancer Epidemiol. Biomarkers Prev., 6, 443-450.
20. Ripple, M.O., Henry, W.F., Rago, R.P. and Wilding, G. (1997) Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. J. Natl Cancer Inst., 89, 40-48.
21. Nelson, W.G., De Marzo, A.M. and DeWeese, T.L. (2001) The molecular pathogenesis of prostate cancer: implications for prostate cancer prevention. Urology, 57 (suppl. 1), 39-45.
22. Chen, J.Z., Gokden, N., Greene, G.F., Mukunyadzi, P. and Kadlubar, F.F. (2002) Extensive somatic mitochondrial mutations in primary prostate cancer using laser capture microdissection. Cancer Res., 62, 6470-6474.
23. Andrews, R.M., Kubacka, I., Chinnery, P.F., Lightowlers, R.N., Turnbull, D.M. and Howell, N. (1999) Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nature Genet., 23, 147.
24. Coffey, D.S. and Isaacs, J.T. (1981) Theory-prostate tumor biology and cell kinetics. Urology, 17, 40-53.
25. Berges, R.R., Vukanovic, J., Epstein, J.I., CarMichel, M., Cisek, L., Johnson, D.E., Veltri, R.W., Walsh, P.C. and Isaacs, J.T. (1995) Implication of cell kinetic changes during the progression of human prostatic cancer. Clin. Cancer Res., 1, 473-480.
26. Ninio, J. (1991) Transient mutators: a semi-quantitative analysis of the influence of translation and transcription errors on mutation rates. Genetics, 129, 957-962.
27. Friedberg, E.C., Wagner, R. and Radman, M. (2002) Specialized DNA polymerases, cellular survival and the genesis of mutations. Science, 296, 1627-1630.
28. Longley, M.J., Nguyen, D., Kunkel, T.A. and Copeland, W.C. (2001) The fidelity of human DNA polymerase gamma with and without exonucleolytic proofreading and the p55 accessory subunit. J. Biol. Chem., 276, 38555-38562.
29. Graziewicz, M.A., Day, B.J. and Copeland, W.C. (2002) The mitochondrial DNA polymerase as a target of oxidative damage. Nucleic Acids Res., 30, 2817-2824.
30. Santos, J.H., Hunakova, L., Chen, Y., Bortner, C. and Van Houten, B. (2003) Cell sorting experiments link persistent mitochondrial DNA damage with loss of mitochondrial membrane potential and apoptotic cell death. J. Biol. Chem., 278, 1728-1734.
31. Yuan, J. and Glazer, P.M. (1998) Mutagenesis induced by the tumor microenvironment. Mutat. Res., 400, 439-446.
32. Stoneking, M. (2000) Hypervariable sites in the mtDNA control region are mutational hotspots. Am. J. Hum. Genet., 67, 1029-1032.
33. Forster, L., Forster, P., Lutz-Bonengel, S., Willkomm, H. and Brinkmann, B. (2002) Natural radioactivity and human mitochondrial DNA mutations. Proc. Natl Acad. Sci. USA, 99, 13950-13954.
34. Davies, K.J. (2000) Oxidative stress, antioxidant defenses and damage removal, repair and replacement systems. IUBMB Life, 50, 279-289.